Youfeng Yang
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Aging top 2%
Papers in
-
- Renal and related cancers 19
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 2
-
- Renal cell carcinoma treatment 24
- Co-authors
- W. Marston Linehan (33 shared papers)William W. Wheaton (1 shared paper)Andrew R. Mullen (1 shared paper)Navdeep S. Chandel (1 shared paper)Pei-Hsuan Chen (1 shared paper)Ralph J. DeBerardinis (1 shared paper)Lucas B. Sullivan (1 shared paper)Eunsook S. Jin (1 shared paper)
- Journals
- Genes Chromosomes and Cancer (5 papers)The Journal of Urology (4 papers)PLoS ONE (3 papers)Oncotarget (3 papers)Developmental Cell (2 papers)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Youfeng Yang
63 papers receiving 3.9k citations
Youfeng Yang's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 1.5k
- Aging 122
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 2.4k
- Biochemistry 126
Countries citing papers authored by Youfeng Yang
This map shows the geographic impact of Youfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youfeng Yang more than expected).
Fields of papers citing papers by Youfeng Yang
This network shows the impact of papers produced by Youfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youfeng Yang. The network helps show where Youfeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Youfeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reductive carboxylation supports growth in tumour cells with defective mitochondria Hit paper breakdown → | 2011 | 1027 |
| 2 | 2014 | 223 | |
| 3 | 2008 | 178 | |
| 4 | 2012 | 177 | |
| 5 | 2005 | 176 | |
| 6 | 2011 | 175 | |
| 7 | 2009 | 167 | |
| 8 | The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. | 2002 | 131 |
| 9 | 2009 | 113 | |
| 10 | 2015 | 98 | |
| 11 | 2010 | 89 | |
| 12 | 2014 | 85 | |
| 13 | 2013 | 84 | |
| 14 | 2012 | 77 | |
| 15 | 2015 | 75 | |
| 16 | 2010 | 70 | |
| 17 | 2017 | 67 | |
| 18 | 2012 | 62 | |
| 19 | 2012 | 52 | |
| 20 | 2013 | 47 |
About Youfeng Yang
Youfeng Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Aging, having authored 63 papers that have together received 3.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Renal and related cancers (19 papers), Cancer Genomics and Diagnostics (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (5 papers), Genetics, Aging, and Longevity in Model Organisms (4 papers), Inflammation biomarkers and pathways (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (1.5k citations), Aging (122 citations), Pulmonary and Respiratory Medicine (1.1k citations), Molecular Biology (2.4k citations) and Biochemistry (126 citations). Youfeng Yang has collaborated with scholars based in United States, China and India. Frequent co-authors include W. Marston Linehan, William W. Wheaton, Andrew R. Mullen, Navdeep S. Chandel, Pei-Hsuan Chen, Ralph J. DeBerardinis, Lucas B. Sullivan, Eunsook S. Jin, Tzuling Cheng and Maria J. Merino. Their work appears in journals such as Genes Chromosomes and Cancer, The Journal of Urology, PLoS ONE, Oncotarget and Developmental Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.